Researchers at the University of Rochester transferred a longevity gene from naked mole rats into laboratory mice, extending their lifespan and improving their health. The gene enhances production of high molecular weight hyaluronic acid, a compound that protects against cancer, reduces inflammation, and promotes healthier aging.
The modified mice demonstrated remarkable improvements over their unmodified counterparts. They showed stronger resistance to tumors, maintained healthier gut function, and exhibited lower levels of age-related inflammation. These results suggest that a single genetic modification targeting hyaluronic acid production can influence multiple aging pathways simultaneously.
Naked mole rats represent an unusual biological outlier. These rodents live 30 years or more in captivity, roughly ten times longer than ordinary rats, and rarely develop cancer. The Rochester team identified hyaluronic acid as a key contributor to their exceptional longevity and decided to test whether this mechanism could transfer to mice.
The experiment succeeded where many genetic interventions fail because it targeted a fundamental aging process rather than a single disease. Hyaluronic acid functions as an extracellular matrix component, affecting inflammation, cellular communication, and tumor suppression across multiple organ systems. By boosting its production, the researchers addressed aging at a biochemical level that influences numerous age-related conditions.
The study carries both promise and limitations. While the results demonstrate proof of concept in mice, translating these findings to humans requires additional research. Genetic therapies face regulatory, safety, and delivery challenges. The team must determine whether similar modifications could work in primates or whether alternative methods, such as pharmaceutical approaches that mimic the gene's effects, might prove more practical.
The research also raises questions about which hyaluronic acid variants matter most and whether introducing this single factor into humans would produce comparable benefits or trigger unexpected side effects. Long-term monitoring of the modified mice will help address these concerns.
These